Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL-Reference-Cited by-同舟云学术

Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL

Published:2000-07-15 Issue:2 Volume:165 Page:948-955
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Chen Ji-Li,Dunbar P. Rod,Gileadi Uzi,Jäger Elke,Gnjatic Sacha,Nagata Yasuhiro,Stockert Elisabeth,Panicali Dennis L.,Chen Yao-Tseng,Knuth Alexander,Old Lloyd J.,Cerundolo Vincenzo

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. Cancer Tumor antigens

2. New Paths in Human Cancer Serology

3. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

4. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

5. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation;Proceedings of the National Academy of Sciences;2024-05-21

2. T Cell Antigen Recognition and Discrimination by Electrochemiluminescence Imaging;Angewandte Chemie International Edition;2023-11-10

3. T Cell Antigen Recognition and Discrimination by Electrochemiluminescence Imaging;Angewandte Chemie;2023-11-10

4. Skin-Grafting and Dendritic Cell “Boosted” Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines;Cells;2023-08-18

5. The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer;Frontiers in Immunology;2023-06-19